– UK, Henley-on-Thames – PowerShares Global Funds Ireland plc announce that Douglas Sharp, Non-Executive Director of the Company has resigned from the Board of the Company with effect from 18 October, 2016.
The Board would like to thank Douglas for his invaluable contribution during his service.
Douglas remains an employee of Invesco.
Further to the approval of the Central Bank of Ireland, the Directors of the Company also wish to announce the appointment of Mr. Graeme Proudfoot as a Non-Executive Director of the Company, effective as of 18 October 2016.
About Graeme Proudfoot
Graeme Proudfoot is Managing Director — EMEA, responsible for the good governance of Invesco’s activities within the EMEA region. He also leads the EMEA region’s engagement in the public affairs arena with governments and regulators across Europe. Additionally, he is responsible for Invesco Perpetual Life and the Specialist Funds business. Mr. Proudfoot joined Invesco in 1992 as a legal advisor. He has held various roles within the Invesco Group, including Group Company Secretary of Invesco plc and Company Solicitor of AMVESCAP plc. Subsequently, he became General Counsel of Invesco Global, with responsibility for legal affairs across jurisdictions in the UK, Europe, Asia and South America. He was later appointed Managing Director of Invesco’s Specialist Funds Division. He has also served on the board of a listed investment company and of a US ‘40 Act fund board. Prior to joining Invesco, Mr. Proudfoot began his career at Wilde Sapte, Solicitors, practicing as a corporate finance lawyer in London and New York.
For more information : http://www.invescopowershares.co.uk/portal/site/ukretailps
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
Comments are closed.